Showing results (331-340 of 617) with videos related to
Sort By:
Pageof 62
Leukemia Research|July 14, 2023
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemiaMaximilian Stahl, Gerard Giblin, Yiwen Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2017
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With MyelofibrosisRuben A Mesa, Jean-Jacques Kiladjian, John V Catalano, et al.Blood Advances|January 31, 2018
Variability of PD-L1 expression in mastocytosisEllen W Hatch, Mary Beth Geeze, Cheyenne Martin, et al.Cold Spring Harbor Molecular Case Studies|May 6, 2016
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier caseBirgit Knoechel, Ami Bhatt, Li Pan, et al.Nature Medicine|December 13, 2006
Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformationTing Xi Liu, Michael W Becker, Jaroslav Jelinek, et al.Cancer Discovery|July 5, 2014
Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199Triona Ni Chonghaile, Justine E Roderick, Cian Glenfield, et al.Cancer|November 24, 2020
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemiaWendy Stock, Giovanni Martinelli, Matthias Stelljes, et al.Annals of Hematology|January 31, 2025
How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024Martin Griesshammer, Haifa Kathrin Al-Ali, Jan-Niklas Eckardt, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 12, 2021
Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosisJuliana Schwaab, Knut Brockow, Philipp Riffel, et al.Haematologica|June 13, 2015
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosisAlessandro M Vannucchi, Hagop M Kantarjian, Jean-Jacques Kiladjian, et al.Pageof 62